Preclinical Potency and Safety Studies of an AAV2-Mediated Gene Therapy Vector for the Treatment of <i>MERTK</i> Associated Retinitis PigmentosaThomas J. Conlon, William W. Hauswirth, Wen‐Tao Deng et al.|Human Gene Therapy Clinical Development|2013Cited by 95
A functional Jak2 tyrosine kinase domain is essential for mouse developmentKristen Frenzel, Peter P. Sayeski, Mario R. Capecchi et al.|Experimental Cell Research|2006Cited by 15